Standout Papers

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in ... 1983 2026 1997 2011 2.4k
  1. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. (1986)
    Anita B. Roberts, Michael B. Sporn et al. Proceedings of the National Academy of Sciences
  2. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. (1993)
    A B Kulkarni, Daniel M. Becker et al. Proceedings of the National Academy of Sciences
  3. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells (1985)
    Rik Derynck, Ellson Y. Chen et al. Nature
  4. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. (1983)
    Richard K. Assoian, Akira Komoriya et al. Journal of Biological Chemistry
  5. Autocrine growth factors and cancer (1985)
    Michael B. Sporn, Anita B. Roberts Nature
  6. Can dietary beta-carotene materially reduce human cancer rates? (1981)
    Richárd Pető, Richard Doll et al. Nature
  7. Some recent advances in the chemistry and biology of transforming growth factor-beta. (1987)
    Michael B. Sporn, Anita B. Roberts et al. The Journal of Cell Biology
  8. Autocrine Secretion and Malignant Transformation of Cells (1980)
    Michael B. Sporn, George J. Todaro New England Journal of Medicine
  9. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. (1987)
    Sharon M. Wahl, Lalage M. Wakefield et al. Proceedings of the National Academy of Sciences
  10. Peptide Growth Factors and Their Receptors (1991)
    健一 新井, James F. Battey et al. Medical Entomology and Zoology
  11. Transforming Growth Factor-β: Biological Function and Chemical Structure (1986)
    Michael B. Sporn, Anita B. Roberts et al. Science
  12. Type beta transforming growth factor: a bifunctional regulator of cellular growth. (1985)
    Anita B. Roberts, Mario A. Anzano et al. Proceedings of the National Academy of Sciences
  13. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 (1990)
    Wayne A. Border, Seiya Okuda et al. Nature
  14. NRF2 and cancer: the good, the bad and the importance of context (2012)
    Michael B. Sporn, Karen T. Liby Nature reviews. Cancer
  15. Expression and secretion of type beta transforming growth factor by activated human macrophages. (1987)
    H C Stevenson, Paul J. Miller et al. Proceedings of the National Academy of Sciences
  16. Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-β (1987)
    Thomas A. Mustoe, Glenn F. Pierce et al. Science
  17. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. (1981)
    Anita B. Roberts, Mario A. Anzano et al. Proceedings of the National Academy of Sciences
  18. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). (1976)
    Michael B. Sporn, Nancy M. Dunlop et al. PubMed
  19. Deactivation of macrophages by transforming growth factor-β (1988)
    Shohko Tsunawaki, Michael B. Sporn et al. Nature
  20. Peptide growth factors are multifunctional (1988)
    Michael B. Sporn, Anita B. Roberts Nature
  21. Role of transforming growth factor-beta in the development of the mouse embryo. (1987)
    Ursula Heine, E. F. Munoz et al. The Journal of Cell Biology
  22. Recent Advances in Chemoprevention of Cancer (1997)
    Waun Ki Hong, Michael B. Sporn Science
  23. Role of retinoids in differentiation and carcinogenesis. (1983)
    Michael B. Sporn, Anita B. Roberts PubMed
  24. Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β) (1993)
    Anita B. Roberts, Michael B. Sporn Growth Factors
  25. Transforming growth factor-beta: recent progress and new challenges. (1992)
    Michael B. Sporn, Anita B. Roberts The Journal of Cell Biology
  26. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. (1986)
    John H. Kehrl, Anita B. Roberts et al. The Journal of Immunology
  27. The tumour microenvironment as a target for chemoprevention (2007)
    Adriana Albini, Michael B. Sporn Nature reviews. Cancer
  28. Transforming Growth Factor‐β (1990)
    Anita B. Roberts, Ursula Heine et al. Annals of the New York Academy of Sciences
  29. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. (1992)
    Ariel Miller, Ofer Lider et al. Proceedings of the National Academy of Sciences
  30. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. (1990)
    Michael E. Joyce, Anita B. Roberts et al. The Journal of Cell Biology
  31. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β (1988)
    Pellegrino Rossi, Gérard Karsenty et al. Cell
  32. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. (1995)
    Nicholas Sanderson, Péter Nagy et al. Proceedings of the National Academy of Sciences
  33. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer (2007)
    Karen T. Liby, Mark M. Yore et al. Nature reviews. Cancer
  34. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. (1988)
    Ellen Van Obberghen‐Schilling, N S Roche et al. Journal of Biological Chemistry
  35. Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. (1986)
    Tohru Masui, Lalage M. Wakefield et al. Proceedings of the National Academy of Sciences
  36. Distribution and modulation of the cellular receptor for transforming growth factor-beta. (1987)
    Lalage M. Wakefield, David M. Smith et al. The Journal of Cell Biology
  37. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. (1988)
    Lalage M. Wakefield, David M. Smith et al. Journal of Biological Chemistry
  38. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. (1986)
    Richard K. Assoian, Michael B. Sporn The Journal of Cell Biology
  39. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. (1984)
    Charles A. Frolik, Leslie Wakefield et al. Journal of Biological Chemistry
  40. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. (1989)
    Thomas B. Connor, Anita B. Roberts et al. Journal of Clinical Investigation

Immediate Impact

9 by Nobel laureates 71 from Science/Nature 144 standout
Sub-graph 1 of 14

Citing Papers

Hallmarks of Cancer: The Next Generation
2011 Standout
Induction and effector functions of TH17 cells
2008 StandoutNature
34 intermediate papers

Works of Michael B. Sporn being referenced

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
1993 Standout
TGF-beta: problems and prospects.
1990
and 38 more

Author Peers

Author Last Decade Papers Cites
Michael B. Sporn 44382 12664 8534 507 72.8k
Carl‐Henrik Heldin 41421 13948 8881 492 62.1k
George D. Yancopoulos 54500 14103 11822 425 101.4k
Harvey F. Lodish 46181 9029 10840 572 76.6k
Roderick T. Bronson 45554 22954 11505 543 76.8k
Josef Penninger 40322 14525 7432 578 76.7k
Toshio Suda 31977 16318 7098 723 57.6k
Roger J. Davis 61987 15513 11579 563 91.7k
Peter Carmeliet 52350 14817 27080 720 98.1k
Napoleone Ferrara 60705 20350 23583 257 97.7k
Mien‐Chie Hung 42788 27578 13565 740 66.0k

All Works

Loading papers...

Rankless by CCL
2026